Bank of America
FRTX

Bank of America’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bank of America’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$2 – 8046
2023
Q2 		$2 Hold
2
– – ﹤0.01% 7650
2023
Q1 		$2 Sell
2
-3
-60% -$5 ﹤0.01% 7723
2022
Q4 		$8 Hold
5
– – ﹤0.01% 8109
2022
Q3 		$0 Sell
5
-2
-29% -$6 ﹤0.01% 8348
2022
Q2 		$0 Hold
7
– – ﹤0.01% 8573
2022
Q1 		$0 Buy
7
+5
+250% +$54 ﹤0.01% 8952
2021
Q4 		$0 Hold
2
– – ﹤0.01% 8814
2021
Q3 		$0 Sell
2
-1
-33% -$32 ﹤0.01% 8503
2021
Q2 		$0 Sell
3
-9
-75% -$370 ﹤0.01% 8211
2021
Q1 		$0 Buy
12
+5
+71% +$275 ﹤0.01% 7894
2020
Q4 		$0 Hold
7
– – ﹤0.01% 7454
2020
Q3 		$0 Sell
7
-30
-81% -$1.18K ﹤0.01% 7274
2020
Q2 		$2K Sell
37
-1
-3% -$53 ﹤0.01% 6693
2020
Q1 		$2K Hold
38
– – ﹤0.01% 6667
2019
Q4 		$2K Sell
38
-7
-16% -$810 ﹤0.01% 6910
2019
Q3 		$8K Buy
45
+1
+2% +$230 ﹤0.01% 6770
2019
Q2 		$11K Buy
44
+5
+13% +$1.68K ﹤0.01% 6714
2019
Q1 		$15K Hold
39
– – ﹤0.01% 6567
2018
Q4 		$15K Sell
39
-24
-38% -$9.41K ﹤0.01% 6559
2018
Q3 		$27K Buy
63
+24
+62% +$10.1K ﹤0.01% 6415
2018
Q2 		$14K Sell
39
-14
-26% -$6.59K ﹤0.01% 6596
2018
Q1 		$24K Buy
53
+14
+36% +$6.95K ﹤0.01% 6329
2017
Q4 		$23K Hold
39
– – ﹤0.01% 6374
2017
Q3 		$29K Hold
39
– – ﹤0.01% 6153
2017
Q2 		$33K Buy
39
+3
+8% +$2.19K ﹤0.01% 6046
2017
Q1 		$26K Hold
36
– – ﹤0.01% 6207
2016
Q4 		$26K Sell
36
-1
-3% -$812 ﹤0.01% 6232
2016
Q3 		$36K Hold
37
– – ﹤0.01% 5869
2016
Q2 		$53K Buy
37
+32
+640% +$41.2K ﹤0.01% 5814
2016
Q1 		$6K Hold
5
– – ﹤0.01% 6539
2015
Q4 		$6K Sell
5
-1
-17% -$1.3K ﹤0.01% 6840
2015
Q3 		$8K Sell
6
-1
-14% -$1.93K ﹤0.01% 6651
2015
Q2 		$15K Buy
7
+5
+250% +$15.7K ﹤0.01% 6458
2015
Q1 		$5K Buy
2
+1
+100% +$3.2K ﹤0.01% 6516
2014
Q4 		$4K Hold
1
– – ﹤0.01% 7350
2014
Q3 		$4K Sell
1
-79
-99% -$307K ﹤0.01% 7629
2014
Q2 		$306K Buy
80
+79
+7,900% +$297K ﹤0.01% 5121
2014
Q1 		$4K Sell
1
-3
-75% -$13.4K ﹤0.01% 7420
2013
Q4 		$17K Buy
4
+2
+100% +$7.58K ﹤0.01% 7099
2013
Q3 		$8K Sell
2
-4
-67% -$30K ﹤0.01% 7256
2013
Q2 		$60K Buy
+6
New +$66.5K ﹤0.01% 6462

Other funds holding FRTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America's FRTX Position: Q3 2023 in Review

Bank of America sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2023, closing a stake of 2 shares — an estimated $2 sold.

Bank of America first reported a position in FRTX in Q2 2013 and held it in 41 quarters. The position peaked at $306K in Q2 2014. 15 funds tracked by Wall St. Rank hold FRTX as of Q3 2023.

  • Bank of America reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bank of America sold 2 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.
  • Bank of America first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 41 quarters.
  • Bank of America's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $306K in Q2 2014.
  • 15 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.